Clinical pathobiochemistry of vitamin B12 deficiency: improving our Understanding by exploring novel mechanisms with a focus on diabetic neuropathy
Silva specializes in evidence-based weight management, including GLP-1 and GIP therapies like tirzepatide to improve metabolic and hormonal health
10Semaglutide oral tablet Semaglutide oral tablet Patients with type 2 diabetes mellitus use semaglutide oral tablets as a medication
and the change in the C-reactive protein (CRP) level
Valenti, Daniela, Fiorenza Stagni, Marco Emili, Sandra Guidi, Renata Bartesaghi, and Rosa Anna Vacca
The SELECT trial showed that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in adults with obesity and established cardiovascular disease, without requiring a diabetes diagnosis. The FLOW trial showed kidney benefits with semaglutide use in patients with type 2 diabetes and chronic kidney disease. Improvements in hard clinical outcomes like cardiac events, kidney disease, and death are commonly observed with GLP-1 use, and are due to both the direct effects of treating the obesity, and indirect effects of the medications themselves
